n Obstetrics and Gynaecology Forum - Cost implications of the use of magnesium sulphate for the prevention of convulsions in severe pre-eclampsia : original article

Volume 15, Issue 3
  • ISSN : 1027-9148



&lt;I&gt;Objective:&lt;/I&gt; To assess the direct financial costs of using MgS0&lt;sub&gt;4&lt;/sub&gt; for the prevention of convulsions in the management of severe pre-eclampsia. &lt;br&gt;&lt;I&gt;Method:&lt;/I&gt; A prospective costing study using resource data obtained from hospital records. Unit costs per patient were calculated. The costs to health provider only, of using or not using MgS0&lt;sub&gt;4&lt;/sub&gt; are reported. &lt;br&gt;&lt;I&gt;Setting:&lt;/I&gt; Department of Obstetrics and Gynaecology of King Edward VIII Hospital, Durban, South Africa. 196 patients records were analysed and reviewed between 1 July and 31 December 2003. &lt;br&gt;&lt;I&gt;Results:&lt;/I&gt; The average unit cost per day for patients on MgS0&lt;sub&gt;4&lt;/sub&gt; was R1575.12 while that of those not on MgS0<sub>4</sub> was R1085.15. &lt;br&gt;&lt;I&gt;Conclusion:&lt;/I&gt; Use of MgS0&lt;sub&gt;4&lt;/sub&gt; to treat the severe pre-eclamptic patient has cost implications but, a case for its use in patients with severe pre-eclampsia can be made.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error